Lerin Tablet
By Lerin
Rx
10 Tablet in a Strip

Composition
Methylergometrine(NA)

Manufacturer - Troikaa Pharmaceuticals Ltd
Troikaa Pharmaceuticals Ltd., Registered Office: , 'Commerce House - 1', Satya Marg, Bodakdev, Ahmedabad-380 054. Gujarat, India.

Expires on or after
September, 2025

liver
Caution should be exercised when using Lerin Tablet in patients with liver disease. Limited information is available regarding the safety of Lerin Tablet in individuals with liver issues. It is advisable to consult with your doctor before using this medication if you have any liver problems to ensure its suitability and safety for your condition.

kidney
Limited information is available on the use of Lerin Tablet in patients with kidney disease. It is advisable to consult your doctor regarding the use of this medication.

alcohol
Consult your doctor when consuming alcohol with Lerin Tablet.

driving
When taking Lerin Tablet, refrain from driving if you have symptoms that impact your ability to concentrate and react. It is uncertain if Lerin Tablet affects driving skills.

pregnancy
Lerin Tablet is considered highly unsafe during pregnancy. It is advised to consult a doctor due to potential harmful effects on the developing baby, based on studies involving pregnant women and animals.

breastfeeding
Lerin Tablet needs caution during breastfeeding. It is advisable to pause breastfeeding until the mother finishes treatment and the drug is out of her system.
Habit Forming | No |
Chemical Class | Ergolines |
Therapeutic Class | - |
Action Class | Uterotonic and abortificient |
₹85
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025